newsfilter
← Latest News
FDA Approved Drugs·

Approval of Nexletol, Nda #211616 (Labeling)

Approval Date: 01/09/2026; Drug Name: Nexletol, Nda #211616; Active Ingredients: BEMPEDOIC ACID; Company: Esperion Theraps Inc; Submission Status: Approval; Submission Classification: Labeling; Application Number: 211616

Company
ESPERION THERAPS INC
Keywords
ESPERION THERAPS INC